MedPath

OZANEX

OZANEX

Dormant
DIN Number

02463504

Drug Class

Human

Market Date

Jan 4, 2018

Company
HC

Ferrer Internacional S.A.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02463504
AIG Number0159010001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
D06AX14 OZENOXACIN
Product Specifications
Dosage FormCream
Route of AdministrationTopical
AHFS Classification84:04.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

OZENOXACINActive
Strength: 1 % / W/W
Monograph: OZENOXACIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.